| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |